vs
CENTRUS ENERGY CORP（LEU）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是CENTRUS ENERGY CORP的1.5倍（$219.9M vs $146.2M），Orthofix Medical Inc.同比增速更快（2.0% vs -3.6%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-58.0M），过去两年CENTRUS ENERGY CORP的营收复合增速更高（82.9% vs 8.0%）
Centrus Energy Corp是美国能源企业，主营核电站所需核燃料供应，同时专注于离心技术的研发与落地推广，生产可应用于商业、政府场景及国家安全领域的浓缩铀产品。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
LEU vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.5倍
$146.2M
营收增速更快
OFIX
高出5.5%
-3.6%
自由现金流更多
OFIX
多$74.8M
$-58.0M
两年增速更快
LEU
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $146.2M | $219.9M |
| 净利润 | — | $-2.2M |
| 毛利率 | 23.9% | 71.1% |
| 营业利润率 | 8.8% | 0.2% |
| 净利率 | — | -1.0% |
| 营收同比 | -3.6% | 2.0% |
| 净利润同比 | — | 92.4% |
| 每股收益（稀释后） | $0.52 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LEUOFIX
| Q4 25 | $146.2M | $219.9M | ||
| Q3 25 | $74.9M | $205.6M | ||
| Q2 25 | $154.5M | $203.1M | ||
| Q1 25 | $73.1M | $193.6M | ||
| Q4 24 | $151.6M | $215.7M | ||
| Q3 24 | $57.7M | $196.6M | ||
| Q2 24 | $189.0M | $198.6M | ||
| Q1 24 | $43.7M | $188.6M |
净利润LEUOFIX
| Q4 25 | — | $-2.2M | ||
| Q3 25 | $3.9M | $-22.8M | ||
| Q2 25 | $28.9M | $-14.1M | ||
| Q1 25 | $27.2M | $-53.1M | ||
| Q4 24 | — | $-29.1M | ||
| Q3 24 | $-5.0M | $-27.4M | ||
| Q2 24 | $30.6M | $-33.4M | ||
| Q1 24 | $-6.1M | $-36.0M |
毛利率LEUOFIX
| Q4 25 | 23.9% | 71.1% | ||
| Q3 25 | -5.7% | 72.2% | ||
| Q2 25 | 34.9% | 68.7% | ||
| Q1 25 | 45.0% | 62.8% | ||
| Q4 24 | 40.8% | 69.0% | ||
| Q3 24 | 15.4% | 68.7% | ||
| Q2 24 | 19.3% | 67.8% | ||
| Q1 24 | 9.8% | 67.5% |
营业利润率LEUOFIX
| Q4 25 | 8.8% | 0.2% | ||
| Q3 25 | -22.2% | -8.3% | ||
| Q2 25 | 21.7% | -7.9% | ||
| Q1 25 | 28.0% | -25.2% | ||
| Q4 24 | 29.7% | -5.3% | ||
| Q3 24 | -13.2% | -9.6% | ||
| Q2 24 | 11.2% | -12.5% | ||
| Q1 24 | -24.3% | -15.6% |
净利率LEUOFIX
| Q4 25 | — | -1.0% | ||
| Q3 25 | 5.2% | -11.1% | ||
| Q2 25 | 18.7% | -6.9% | ||
| Q1 25 | 37.2% | -27.4% | ||
| Q4 24 | — | -13.5% | ||
| Q3 24 | -8.7% | -13.9% | ||
| Q2 24 | 16.2% | -16.8% | ||
| Q1 24 | -14.0% | -19.1% |
每股收益（稀释后）LEUOFIX
| Q4 25 | $0.52 | $-0.05 | ||
| Q3 25 | $0.19 | $-0.57 | ||
| Q2 25 | $1.59 | $-0.36 | ||
| Q1 25 | $1.60 | $-1.35 | ||
| Q4 24 | $3.26 | $-0.76 | ||
| Q3 24 | $-0.30 | $-0.71 | ||
| Q2 24 | $1.89 | $-0.88 | ||
| Q1 24 | $-0.38 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.0B | $82.0M |
| 总债务越低越好 | $1.2B | — |
| 股东权益账面价值 | $765.1M | $450.0M |
| 总资产 | $2.4B | $850.6M |
| 负债/权益比越低杠杆越低 | 1.54× | — |
8季度趋势，按日历期对齐
现金及短期投资LEUOFIX
| Q4 25 | $2.0B | $82.0M | ||
| Q3 25 | $1.6B | $62.9M | ||
| Q2 25 | $833.0M | $65.6M | ||
| Q1 25 | $653.0M | $58.0M | ||
| Q4 24 | $671.4M | $83.2M | ||
| Q3 24 | $194.3M | $30.1M | ||
| Q2 24 | $227.0M | $26.4M | ||
| Q1 24 | $209.3M | $27.0M |
总债务LEUOFIX
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | $157.2M | ||
| Q2 25 | $390.0M | $157.0M | ||
| Q1 25 | $389.5M | $156.9M | ||
| Q4 24 | $472.5M | $157.0M | ||
| Q3 24 | $83.5M | $118.5M | ||
| Q2 24 | $86.5M | $118.0M | ||
| Q1 24 | $86.5M | $118.2M |
股东权益LEUOFIX
| Q4 25 | $765.1M | $450.0M | ||
| Q3 25 | $363.1M | $442.5M | ||
| Q2 25 | $359.1M | $458.3M | ||
| Q1 25 | $213.9M | $458.3M | ||
| Q4 24 | $161.4M | $503.1M | ||
| Q3 24 | $76.4M | $525.9M | ||
| Q2 24 | $76.6M | $546.0M | ||
| Q1 24 | $33.8M | $570.3M |
总资产LEUOFIX
| Q4 25 | $2.4B | $850.6M | ||
| Q3 25 | $2.2B | $832.6M | ||
| Q2 25 | $1.3B | $837.2M | ||
| Q1 25 | $1.3B | $823.1M | ||
| Q4 24 | $1.1B | $893.3M | ||
| Q3 24 | $591.0M | $867.9M | ||
| Q2 24 | $668.2M | $882.0M | ||
| Q1 24 | $750.0M | $906.0M |
负债/权益比LEUOFIX
| Q4 25 | 1.54× | — | ||
| Q3 25 | 3.23× | 0.36× | ||
| Q2 25 | 1.09× | 0.34× | ||
| Q1 25 | 1.82× | 0.34× | ||
| Q4 24 | 2.93× | 0.31× | ||
| Q3 24 | 1.09× | 0.23× | ||
| Q2 24 | 1.13× | 0.22× | ||
| Q1 24 | 2.56× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-48.4M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-58.0M | $16.8M |
| 自由现金流率自由现金流/营收 | -39.7% | 7.6% |
| 资本支出强度资本支出/营收 | 6.6% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $31.3M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流LEUOFIX
| Q4 25 | $-48.4M | $27.7M | ||
| Q3 25 | $10.1M | $12.4M | ||
| Q2 25 | $52.8M | $11.6M | ||
| Q1 25 | $36.5M | $-18.4M | ||
| Q4 24 | $57.9M | $23.7M | ||
| Q3 24 | $-33.2M | $11.7M | ||
| Q2 24 | $7.0M | $9.0M | ||
| Q1 24 | $5.3M | $-18.6M |
自由现金流LEUOFIX
| Q4 25 | $-58.0M | $16.8M | ||
| Q3 25 | $5.7M | $2.5M | ||
| Q2 25 | $49.2M | $4.5M | ||
| Q1 25 | $34.4M | $-25.1M | ||
| Q4 24 | $57.2M | $15.2M | ||
| Q3 24 | $-34.2M | $6.3M | ||
| Q2 24 | $6.1M | $-360.0K | ||
| Q1 24 | $3.8M | $-29.1M |
自由现金流率LEUOFIX
| Q4 25 | -39.7% | 7.6% | ||
| Q3 25 | 7.6% | 1.2% | ||
| Q2 25 | 31.8% | 2.2% | ||
| Q1 25 | 47.1% | -13.0% | ||
| Q4 24 | 37.7% | 7.0% | ||
| Q3 24 | -59.3% | 3.2% | ||
| Q2 24 | 3.2% | -0.2% | ||
| Q1 24 | 8.7% | -15.4% |
资本支出强度LEUOFIX
| Q4 25 | 6.6% | 4.9% | ||
| Q3 25 | 5.9% | 4.8% | ||
| Q2 25 | 2.3% | 3.5% | ||
| Q1 25 | 2.9% | 3.5% | ||
| Q4 24 | 0.5% | 4.0% | ||
| Q3 24 | 1.7% | 2.7% | ||
| Q2 24 | 0.5% | 4.7% | ||
| Q1 24 | 3.4% | 5.6% |
现金转化率LEUOFIX
| Q4 25 | — | — | ||
| Q3 25 | 2.59× | — | ||
| Q2 25 | 1.83× | — | ||
| Q1 25 | 1.34× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.23× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LEU
| Separative Work Units | $111.0M | 76% |
| Services | $21.8M | 15% |
| Other | $13.4M | 9% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
